$9.58
+0.31 (+3.34%)
Open$9.27
Previous Close$9.27
Day High$9.89
Day Low$9.01
52W High$12.74
52W Low$6.47
Volume—
Avg Volume34.7K
Market Cap53.19M
P/E Ratio—
EPS$-3.51
SectorBiotechnology
Analyst Ratings
Strong Buy
5 analysts
Price Target
+421.3% upside
Current
$9.58
$9.58
Target
$49.94
$49.94
$27.43
$49.94 avg
$65.11
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 30.77M | 12.59M | 12.91M |
| Net Income | -24,633,112 | -1,338,243 | -1,683,285 |
| Profit Margin | -80.1% | -10.6% | -13.0% |
| EBITDA | -28,433,220 | -1,969,871 | -1,762,148 |
| Free Cash Flow | — | -1,414,748 | -1,276,245 |
| Rev Growth | — | -1.9% | -7.4% |
| Debt/Equity | — | 1.05 | 0.93 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |